Trial Profile
Pre-surgical effects of serms, anti-COX-2 and aromatase inhibitors in breast cancer patients: a phase II randomized controlled trial
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 13 Apr 2019
Price :
$35
*
At a glance
- Drugs Celecoxib (Primary) ; Exemestane (Primary) ; Raloxifene (Primary) ; Tamoxifen (Primary)
- Indications Breast cancer
- Focus Biomarker; Therapeutic Use
- 18 Sep 2012 New trial record